Selina Chen-Kiang

Selina Chen-Kiang is an immunologist and cancer researcher whose work focuses on cell cycle control of B cell immunity and cancer, with particular emphasis on mantle cell lymphoma. She has received multiple grants from the Leukemia and Lymphoma Society over the past two decades, enabling her seminal work on therapies that target enzymes implicated in multiple cancers. She was awarded an NCI Program Project Grant from NIH/NCI in excess of $9 million for five years.

• Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib with bortezomib and dexamethasone in relapsed/refractory multiple myeloma (2015) Paper
• CDK4/6 Inhibition Reverses MEIS2 Suppression of CRL4CRBN to Enhance Immunomodulatory Drug Therapy in Multiple Myeloma (2025) Paper